Dosing · Repair · BPC-157 5MG
Repair · Body Protection Complex

BPC-157 5MG

A synthetic peptide modelled on a naturally occurring gastric protein — supports tissue repair, angiogenesis, and gut-lining integrity.

29,00 € 5 mg vial In stock
Per reference10units
Cadence5× per week
Dose250MCG
Vial5mg / 2 mL
BPC-157 5MG

About

A synthetic peptide derived from a protein naturally present in gastric fluid.

Research describes BPC-157 as a cytoprotective and regenerative agent with effects on muscle, tendon, ligament, nerve, and gastrointestinal tissue. The literature emphasises injury recovery, chronic inflammation, post-surgical healing, and gut-lining repair.

Sequence lists BPC-157 under the Repair category - tissue, gut, injury.

Vial content

5 mg lyophilised BPC-157 in a glass vial at 2.5 mg/mL after reconstitution with BAC water.

At reference, 10 units on a U-50 insulin syringe draws approximately 250 mcg. Rotate between abdominal quadrants, outer thighs, and upper arms — never repeat a site within the week.

Storage: refrigerated 2–8°C after reconstitution. Do not freeze.

Reported effects

What the literature
describes.

01

Tendon, ligament, muscle healing

02

Joint & soft-tissue inflammation

03

Nerve repair & functional recovery

04

Gut lining & ulcer protection

05

Post-surgical & scar modulation

Reported timeline

What the literature
reports, by phase.

Week 1–2
01

Week 1–2 — Initial reduction in acute inflammation. Early calming of injection-site reactions and tissue tension.

Week 3–6
02

Week 3–6 — Connective-tissue pliability. Early gut comfort. Reported improvements in joint mobility.

Week 6–12
03

Week 6–12 — Consolidation of tendon and ligament repair. Reduction in chronic inflammation markers.

Long-term
04

Long-term — Sustained tissue resilience post-cycle. Reported retention of gains through the off-phase.

Reference dosing

Reference profile.

Baseline

Standard
20units / injection
250 mcg · 5× per week (Monday–Friday)
  • Injection siteSubcutaneous · abdomen, thigh, upper arm
  • RotationQuadrant cycle, avoid repeat sites
  • TimingEvening preferred — aligns with nighttime repair

Baseline

Agressive
40units / injection
500 mcg · 5× per week (Monday–Friday)
  • Injection siteSubcutaneous · abdomen, thigh, upper arm
  • RotationQuadrant cycle, avoid repeat sites
  • TimingEvening preferred — aligns with nighttime repair

Recommended cycle

8-12 Weeks depending on injury

Cycling allows signalling pathways to recalibrate. The off-phase is not inactivity — it's the system holding gains without continuous exogenous input.

Vial details

ContentBPC-157 · lyophilised
Mass5 mg
Reconstitution2 mL water
Concentration2.5 mg/mL
Supply (baseline)~4 weeks
Storage36–46°F · 2–8°C · do not freeze
Mechanism

Angiogenesis. Collagen. Signalling.

Research describes BPC-157 as acting on multiple tissue-repair pathways - angiogenesis via VEGF signalling, collagen production in fibroblasts, nitric oxide regulation, and modulation of inflammatory cytokines.

Effects on the gastrointestinal tract appear linked to the peptide's gastric-protein origin; effects on musculoskeletal tissue appear linked to its angiogenic and fibroblast-stimulating properties.

  • AngiogenesisVEGF up-regulation supports new capillary formation at injury sites.
  • CollagenFibroblast stimulation increases collagen synthesis — foundational for tendon and ligament repair.
  • Nitric oxideNO modulation supports vascular tone and cellular signalling at the repair site.
  • InflammationDown-regulation of pro-inflammatory cytokines without full immune suppression.
Safety signals

Reported side effects
& contraindications.

Reported side effects
  • Injection-site redness, tenderness, or mild bruising
  • Mild soreness at the application site
  • Transient joint discomfort or tingling
  • Occasional nausea or headaches during the first week
Contraindications
  • Active malignancy
  • Pregnancy or breastfeeding
  • Known peptide or excipient hypersensitivity
Discontinue and seek medical advice

Severe swelling at the injection site, fever above 38°C, worsening fatigue, rash, breathing difficulty, or facial swelling — discontinue and contact a clinician.

Research chemical · Not for human consumption. This reference is educational only. Sequence does not provide medical services or prescribe. Consult a licensed clinician for any health decision.

Watch it done properly.

Reconstitution, site rotation, storage — on video.

Video guide Back to dosing